HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Brattström Selected Research

Ze 339

5/2010Petasites extract Ze 339 (PET) inhibits allergen-induced Th2 responses, airway inflammation and airway hyperreactivity in mice.
1/2006The butterbur extract petasin has no effect on skin test reactivity induced by different stimuli: a randomized, double-blind crossover study using histamine, codeine, methacholine, and aeroallergen solutions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Brattström Research Topics

Disease

2Inflammation (Inflammations)
07/2010 - 05/2010
2Asthma (Bronchial Asthma)
07/2010 - 05/2010
2Respiratory Hypersensitivity
07/2010 - 05/2010
1Sleep Wake Disorders
09/2007
1Hypersensitivity (Allergy)
01/2006
1Seasonal Allergic Rhinitis (Hay Fever)
01/2006
1Hemorrhage
03/2002
1Infarction (Infarctions)
03/2002
1Myocardial Infarction
03/2002
1Sleep Initiation and Maintenance Disorders (Insomnia)
09/2000

Drug/Important Bio-Agent (IBA)

2Chemokine CCL5IBA
07/2010 - 05/2010
2CytokinesIBA
07/2010 - 05/2010
2Immunoglobulin E (IgE)IBA
07/2010 - 05/2010
2Interleukin-5 (Interleukin 5)IBA
07/2010 - 05/2010
2AllergensIBA
07/2010 - 05/2010
2AntigensIBA
07/2010 - 05/2010
2Interleukin-4 (Interleukin 4)IBA
07/2010 - 05/2010
2OvalbuminIBA
07/2010 - 05/2010
2Ze 339IBA
05/2010 - 01/2006
2HovaIBA
09/2007 - 09/2000
1Carbon DioxideIBA
07/2010
1LeukotrienesIBA
05/2010
1Histamine Antagonists (Antihistamines)IBA
01/2006
1petasinIBA
01/2006
1Anti-Allergic Agents (Antiallergic Agents)IBA
01/2006
1acrivastine (Semprex)FDA Link
01/2006
1Glycoproteins (Glycoprotein)IBA
03/2002
1Tirofiban (Aggrastat)FDA Link
03/2002
1Tissue Plasminogen Activator (Alteplase)FDA Link
03/2002

Therapy/Procedure

1Therapeutics
03/2002